China Facial Injectables Market Research Report 2017

December 2017 | 110 pages | ID: CB5B075931AEN
QYResearch

Abstracts

The global Facial Injectables market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Facial Injectables development status and future trend in China, focuses on top players in China, also splits Facial Injectables by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Allergan
• Prollenium Medical Technologies Inc
• Galderma
• Merz Aesthetics
• Ipsen Group
• Bloomage BioTechnology
• Hangzhou Techderm Biological Products
• Laboratory Obvieline
• Medytox
• Polymekon
• Qufu Guanglong Biochem
• Revitacare
• Suneva Medical
• SciVision Biotech
• Speciality European Pharma
• Syneron
• Visionmed
• AQTIS Medical

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K Doses), revenue (Million USD), product price (USD/Dose), market share and growth rate of each type, primarily split into

• Botulinum Toxin
• Hyaluronic Acid
• Collagen
• Particle & Polymer Fillers (PPF)

On the basis of the end users/application, this report covers

• Hospitals
• Ambulatory Surgical Centers
• Cosmetic Centers
• Dermatology Clinics
• Physician Clinics

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Facial Injectables Market Research Report 2017

1 FACIAL INJECTABLES OVERVIEW

1.1 Product Overview and Scope of Facial Injectables
1.2 Classification of Facial Injectables by Product Category
  1.2.1 China Facial Injectables Sales (K Doses) Comparison by Type (2012-2022)
  1.2.2 China Facial Injectables Sales (K Doses) Market Share by Type in 2016
  1.2.3 Botulinum Toxin
  1.2.4 Hyaluronic Acid
  1.2.5 Collagen
  1.2.6 Particle & Polymer Fillers (PPF)
1.3 China Facial Injectables Market by Application/End Users
  1.3.1 China Facial Injectables Sales (K Doses) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Hospitals
  1.3.3 Ambulatory Surgical Centers
  1.3.4 Cosmetic Centers
  1.3.5 Dermatology Clinics
  1.3.6 Physician Clinics
1.4 China Facial Injectables Market by Region
  1.4.1 China Facial Injectables Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China Facial Injectables Status and Prospect (2012-2022)
  1.4.3 East China Facial Injectables Status and Prospect (2012-2022)
  1.4.4 Southwest China Facial Injectables Status and Prospect (2012-2022)
  1.4.5 Northeast China Facial Injectables Status and Prospect (2012-2022)
  1.4.6 North China Facial Injectables Status and Prospect (2012-2022)
  1.4.7 Central China Facial Injectables Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Facial Injectables (2012-2022)
  1.5.1 China Facial Injectables Sales (K Doses) and Growth Rate (%)(2012-2022)
  1.5.2 China Facial Injectables Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA FACIAL INJECTABLES MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Facial Injectables Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Facial Injectables Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Facial Injectables Average Price (USD/Dose) by Players/Manufacturers (2012-2017)
2.4 China Facial Injectables Market Competitive Situation and Trends
  2.4.1 China Facial Injectables Market Concentration Rate
  2.4.2 China Facial Injectables Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Facial Injectables Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA FACIAL INJECTABLES SALES AND REVENUE BY REGION (2012-2017)

3.1 China Facial Injectables Sales (K Doses) and Market Share by Region (2012-2017)
3.2 China Facial Injectables Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Facial Injectables Price (USD/Dose) by Regions (2012-2017)

4 CHINA '&B1&' SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)'

4.1 China Facial Injectables Sales (K Doses) and Market Share by Type/ Product Category (2012-2017)
4.2 China Facial Injectables Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Facial Injectables Price (USD/Dose) by Type (2012-2017)
4.4 China Facial Injectables Sales Growth Rate (%) by Type (2012-2017)

5 CHINA '&B1&' SALES BY APPLICATION (2012-2017)'

5.1 China Facial Injectables Sales (K Doses) and Market Share by Application (2012-2017)
5.2 China Facial Injectables Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA FACIAL INJECTABLES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Allergan
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Facial Injectables Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Allergan Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Prollenium Medical Technologies Inc
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Facial Injectables Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Prollenium Medical Technologies Inc Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Galderma
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Facial Injectables Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Galderma Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merz Aesthetics
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Facial Injectables Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merz Aesthetics Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Ipsen Group
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Facial Injectables Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Ipsen Group Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bloomage BioTechnology
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Facial Injectables Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bloomage BioTechnology Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Hangzhou Techderm Biological Products
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Facial Injectables Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Hangzhou Techderm Biological Products Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Laboratory Obvieline
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Facial Injectables Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Laboratory Obvieline Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Medytox
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Facial Injectables Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Medytox Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Polymekon
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Facial Injectables Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Polymekon Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Qufu Guanglong Biochem
6.12 Revitacare
6.13 Suneva Medical
6.14 SciVision Biotech
6.15 Speciality European Pharma
6.16 Syneron
6.17 Visionmed
6.18 AQTIS Medical

7 FACIAL INJECTABLES MANUFACTURING COST ANALYSIS

7.1 Facial Injectables Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Facial Injectables

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Facial Injectables Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Facial Injectables Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA FACIAL INJECTABLES MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China Facial Injectables Sales (K Doses), Revenue (Million USD) Forecast (2017-2022)
11.2 China Facial Injectables Sales (K Doses) Forecast by Type (2017-2022)
11.3 China Facial Injectables Sales (K Doses) Forecast by Application (2017-2022)
11.4 China Facial Injectables Sales (K Doses) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Facial Injectables Sales (K Doses) and Revenue (Million USD) Market Split by Product Type
Table Facial Injectables Sales (K Doses) by Application (2016-2022)
Figure Product Picture of Facial Injectables
Table China Facial Injectables Sales (K Doses) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Facial Injectables Sales Volume Market Share by Types in 2016
Figure Botulinum Toxin Product Picture
Figure Hyaluronic Acid Product Picture
Figure Collagen Product Picture
Figure Particle & Polymer Fillers (PPF) Product Picture
Figure China Facial Injectables Sales (K Doses) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Facial Injectables by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Ambulatory Surgical Centers Examples
Table Key Downstream Customer in Ambulatory Surgical Centers
Figure Cosmetic Centers Examples
Table Key Downstream Customer in Cosmetic Centers
Figure Dermatology Clinics Examples
Table Key Downstream Customer in Dermatology Clinics
Figure Physician Clinics Examples
Table Key Downstream Customer in Physician Clinics
Figure South China Facial Injectables Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Facial Injectables Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Facial Injectables Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Facial Injectables Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Facial Injectables Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Facial Injectables Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Facial Injectables Sales (K Doses) and Growth Rate (%)(2012-2022)
Figure China Facial Injectables Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Facial Injectables Sales of Key Players/Manufacturers (2012-2017)
Table China Facial Injectables Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Facial Injectables Sales Share (%) by Players/Manufacturers
Figure 2017 China Facial Injectables Sales Share (%) by Players/Manufacturers
Table China Facial Injectables Revenue by Players/Manufacturers (2012-2017)
Table China Facial Injectables Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Facial Injectables Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Facial Injectables Revenue Market Share (%) by Players/Manufacturers
Table China Market Facial Injectables Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Facial Injectables Average Price of Key Players/Manufacturers in 2016
Figure China Facial Injectables Market Share of Top 3 Players/Manufacturers
Figure China Facial Injectables Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Facial Injectables Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Facial Injectables Product Category
Table China Facial Injectables Sales (K Doses) by Regions (2012-2017)
Table China Facial Injectables Sales Share (%) by Regions (2012-2017)
Figure China Facial Injectables Sales Share (%) by Regions (2012-2017)
Figure China Facial Injectables Sales Market Share (%) by Regions in 2016
Table China Facial Injectables Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Facial Injectables Revenue Market Share (%) by Regions (2012-2017)
Figure China Facial Injectables Revenue Market Share (%) by Regions (2012-2017)
Figure China Facial Injectables Revenue Market Share (%) by Regions in 2016
Table China Facial Injectables Price (USD/Dose) by Regions (2012-2017)
Table China Facial Injectables Sales (K Doses) by Type (2012-2017)
Table China Facial Injectables Sales Share (%) by Type (2012-2017)
Figure China Facial Injectables Sales Share (%) by Type (2012-2017)
Figure China Facial Injectables Sales Market Share (%) by Type in 2016
Table China Facial Injectables Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Facial Injectables Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Facial Injectables by Type (2012-2017)
Figure Revenue Market Share of Facial Injectables by Type in 2016
Table China Facial Injectables Price (USD/Dose) by Types (2012-2017)
Figure China Facial Injectables Sales Growth Rate (%) by Type (2012-2017)
Table China Facial Injectables Sales (K Doses) by Applications (2012-2017)
Table China Facial Injectables Sales Market Share (%) by Applications (2012-2017)
Figure China Facial Injectables Sales Market Share (%) by Application (2012-2017)
Figure China Facial Injectables Sales Market Share (%) by Application in 2016
Table China Facial Injectables Sales Growth Rate (%) by Application (2012-2017)
Figure China Facial Injectables Sales Growth Rate (%) by Application (2012-2017)
Table Allergan Facial Injectables Basic Information List
Table Allergan Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
Figure Allergan Facial Injectables Sales (K Doses) and Growth Rate (%)(2012-2017)
Figure Allergan Facial Injectables Sales Market Share (%) in China (2012-2017)
Figure Allergan Facial Injectables Revenue Market Share (%) in China (2012-2017)
Table Prollenium Medical Technologies Inc Facial Injectables Basic Information List
Table Prollenium Medical Technologies Inc Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
Figure Prollenium Medical Technologies Inc Facial Injectables Sales (K Doses) and Growth Rate (%)(2012-2017)
Figure Prollenium Medical Technologies Inc Facial Injectables Sales Market Share (%) in China (2012-2017)
Figure Prollenium Medical Technologies Inc Facial Injectables Revenue Market Share (%) in China (2012-2017)
Table Galderma Facial Injectables Basic Information List
Table Galderma Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
Figure Galderma Facial Injectables Sales (K Doses) and Growth Rate (%)(2012-2017)
Figure Galderma Facial Injectables Sales Market Share (%) in China (2012-2017)
Figure Galderma Facial Injectables Revenue Market Share (%) in China (2012-2017)
Table Merz Aesthetics Facial Injectables Basic Information List
Table Merz Aesthetics Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
Figure Merz Aesthetics Facial Injectables Sales (K Doses) and Growth Rate (%)(2012-2017)
Figure Merz Aesthetics Facial Injectables Sales Market Share (%) in China (2012-2017)
Figure Merz Aesthetics Facial Injectables Revenue Market Share (%) in China (2012-2017)
Table Ipsen Group Facial Injectables Basic Information List
Table Ipsen Group Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
Figure Ipsen Group Facial Injectables Sales (K Doses) and Growth Rate (%)(2012-2017)
Figure Ipsen Group Facial Injectables Sales Market Share (%) in China (2012-2017)
Figure Ipsen Group Facial Injectables Revenue Market Share (%) in China (2012-2017)
Table Bloomage BioTechnology Facial Injectables Basic Information List
Table Bloomage BioTechnology Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
Figure Bloomage BioTechnology Facial Injectables Sales (K Doses) and Growth Rate (%)(2012-2017)
Figure Bloomage BioTechnology Facial Injectables Sales Market Share (%) in China (2012-2017)
Figure Bloomage BioTechnology Facial Injectables Revenue Market Share (%) in China (2012-2017)
Table Hangzhou Techderm Biological Products Facial Injectables Basic Information List
Table Hangzhou Techderm Biological Products Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
Figure Hangzhou Techderm Biological Products Facial Injectables Sales (K Doses) and Growth Rate (%)(2012-2017)
Figure Hangzhou Techderm Biological Products Facial Injectables Sales Market Share (%) in China (2012-2017)
Figure Hangzhou Techderm Biological Products Facial Injectables Revenue Market Share (%) in China (2012-2017)
Table Laboratory Obvieline Facial Injectables Basic Information List
Table Laboratory Obvieline Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
Figure Laboratory Obvieline Facial Injectables Sales (K Doses) and Growth Rate (%)(2012-2017)
Figure Laboratory Obvieline Facial Injectables Sales Market Share (%) in China (2012-2017)
Figure Laboratory Obvieline Facial Injectables Revenue Market Share (%) in China (2012-2017)
Table Medytox Facial Injectables Basic Information List
Table Medytox Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
Figure Medytox Facial Injectables Sales (K Doses) and Growth Rate (%)(2012-2017)
Figure Medytox Facial Injectables Sales Market Share (%) in China (2012-2017)
Figure Medytox Facial Injectables Revenue Market Share (%) in China (2012-2017)
Table Polymekon Facial Injectables Basic Information List
Table Polymekon Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
Figure Polymekon Facial Injectables Sales (K Doses) and Growth Rate (%)(2012-2017)
Figure Polymekon Facial Injectables Sales Market Share (%) in China (2012-2017)
Figure Polymekon Facial Injectables Revenue Market Share (%) in China (2012-2017)
Table Qufu Guanglong Biochem Facial Injectables Basic Information List
Table Revitacare Facial Injectables Basic Information List
Table Suneva Medical Facial Injectables Basic Information List
Table SciVision Biotech Facial Injectables Basic Information List
Table Speciality European Pharma Facial Injectables Basic Information List
Table Syneron Facial Injectables Basic Information List
Table Visionmed Facial Injectables Basic Information List
Table AQTIS Medical Facial Injectables Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Facial Injectables
Figure Manufacturing Process Analysis of Facial Injectables
Figure Facial Injectables Industrial Chain Analysis
Table Raw Materials Sources of Facial Injectables Major Players/Manufacturers in 2016
Table Major Buyers of Facial Injectables
Table Distributors/Traders List
Figure China Facial Injectables Sales (K Doses) and Growth Rate (%) Forecast (2017-2022)
Figure China Facial Injectables Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Facial Injectables Price (USD/Dose) Trend Forecast (2017-2022)
Table China Facial Injectables Sales (K Doses) Forecast by Type (2017-2022)
Figure China Facial Injectables Sales (K Doses) Forecast by Type (2017-2022)
Figure China Facial Injectables Sales Volume Market Share Forecast by Type in 2022
Table China Facial Injectables Sales (K Doses) Forecast by Application (2017-2022)
Figure China Facial Injectables Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Facial Injectables Sales Volume Market Share Forecast by Application in 2022
Table China Facial Injectables Sales (K Doses) Forecast by Regions (2017-2022)
Table China Facial Injectables Sales Volume Share Forecast by Regions (2017-2022)
Figure China Facial Injectables Sales Volume Share Forecast by Regions (2017-2022)
Figure China Facial Injectables Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources